Pinusolide improves high glucose-induced insulin resistance via activation of AMP-activated protein kinase

Biochemical and Biophysical Research Communications

Volumn 437, Issue 3, 2013, Pages 374-379

  Hwang, Seung Lark ^a   Jeong, Yong Tae ^a   Hye Yang, Ju ^a   Li, Xian ^a   Lu, Yue ^a   Son, Jong Keun ^a   Chang, Hyeun Wook ^a  

^a Yeungnam University   (South Korea)

Author keywords

AMP activated protein kinase; High glucose; Insulin resistance; L6 myotubes; Pinusolide

Indexed keywords

GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN RECEPTOR SUBSTRATE 1; PINUSOLIDE; PROTEIN KINASE LKB1; SMALL INTERFERING RNA; TERPENE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GLUCOSE TRANSPORT; INSULIN RESISTANCE; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; STIMULATION;

AMP-ACTIVATED PROTEIN KINASE; HIGH GLUCOSE; INSULIN RESISTANCE; L6 MYOTUBES; PINUSOLIDE;

ANIMALS; CELLS, CULTURED; DEOXYGLUCOSE; DITERPENES; ENZYME ACTIVATION; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; MEDICINE, KOREAN TRADITIONAL; MUSCLE FIBERS, SKELETAL; PHOSPHORYLATION; PLANT EXTRACTS; PROTEIN-SERINE-THREONINE KINASES; RATS; SIGNAL TRANSDUCTION; THUJA;

EID: 84880939185     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.06.084     Document Type: Article

References (32)

1. Rossetti L., Smith D., Shulman G.I., Papachristou D., DeFronzo R.A. Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J Clin Invest 1987, 79:1510-1515.
2. Müller H.K., Kellerer M., Ermel B., Muhlhofer A., Obermaier-Kusser B., Vogt B., Härting H.U. Prevention by protein kinase C inhibitors of glucose-induced insulin-receptor tyrosine kinase resistance in rat fat cells. Diabetes 1991, 40:1440-1448.
3. Maegawa H., Shigeta Y., Egawa K., Kobayashi M. Impaired autophosphorylation of insulin receptors from abdominal skeletal muscles in nonobese subjects with NIDDM. Diabetes 1991, 40:815-819.
4. Hardie D.G., Scott J.W., Pan D.A., Hudson E.R. Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett 2003, 546:113-120.
5. Carling D. The AMP-activated protein kinase cascade-a unifying system for energy control. Trends Biochem Sci 2004, 29:18-24.
6. Kurth-Kraczek E.J., Hirshman M.F., Goodyear L.J., Winder W.W. 5' AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes 1999, 48:1667-1671.
7. Russell R.R., Bergeron R., Shulman G.I., Young L.H. Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. Am J Physiol 1999, 277:H643-H649.
8. Merrill G.F., Kurth E.J., Hardie D.G., Winder W.W. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am J Physiol 1997, 273:E1107-E1112.
9. Mu J., Brozinick J.T.Jr., Bucan M., Birnbaum M.J. A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. Mol Cell 2001, 7:1085-1094.
10. Buhl E.S., Jessen N., Pold R., Ledet T., Flyvbjerg A., Pedersen S.B., Pedersen O., Schmitz O., Lund S. Long-term AICAR administration reduces metabolic disturbances and lowers blood pressure in rats displaying features of the insulin resistance syndrome. Diabetes 2002, 51:2199-2206.
11. Fedele D., Tiengo A., Nosadini R., Marchiori E., Briani G., Garotti M.C., Muggeo M. Hypolipidemic effects of metformin in hyperprebetalipoproteinemia. Diabetes Metab 1976, 2:127-133.
12. Hermann L.S. Metformin: a review of its pharmacological properties and therapeutic use. Diabetes Metab 1979, 5:233-245.
13. Davidson M.B., Peters A.L. An overview of metformin in the treatment of type 2 diabetes mellitus. Am J Med 1997, 102:99-110.
14. Yang H.O., Kang Y.H., Suh D.Y., Kim Y.C., Han B.H. Biological and pharmacological effects of pinusolide, a novel platelet activating factor antagonist. Planta Med 1995, 61:519-522.
15. Zhu J.X., Wang Y., Kong L.D., Yang C., Zhang X. Effects of Biota orientalis extract and its flavonoid constituents, quercetin and rutin on serum uric acid levels in oxonate-induced mice and xanthine dehydrogenase and xanthine oxidase activities in mouse liver. J Ethnopharmacol 2004, 93:133-140.
16. Koo K.A., Sung S.H., Kim Y.C. A new neuroprotective pinusolide derivative from the leaves of Biota orientalis. Chem Pharm Bull 2002, 50:834-836.
17. Kim K.A., Moon T.C., Lee S.W., Chung K.C., Han B.H., Chang H.W. Pinusolide from the leaves of Biota orientalis as potent platelet activating factor antagonist. Planta Med 1999, 65:39-42.
18. Hwang S.L., Li X., Lee J.Y., Chang H.W. Improved insulin sensitivity by rapamycin is associated with reduction of mTOR and S6K1 activities in L6 myotubes. Biochem Biophys Res Commun 2012, 418:402-407.
19. Hwang S.L., Chang H.W., Lee I.K., Yang B.K., Magae J., Chang Y.C. Ascofuranone prevents ER stress-induced insulin resistance via activation of AMP-activated protein kinase in L6 myotube cells. Biochem Biophys Res Commun 2010, 396:967-972.
20. Xue B., Kahn B.B. AMPK integrates nutrient and hormonal signals to regulate food intake and energy balance through effects in the hypothalamus and peripheral tissues. J Physiol 2006, 574:73-83.
21. Kahn B.B., Alquier T., Carling D., Hardie D.G. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 2005, 1:15-25.
22. Long Y.C., Zierath J.R. AMP-activated protein kinase signaling in metabolic regulation. J Clin Invest 2006, 116:1776-1783.
23. Koh H.J., Arnolds D.E., Fujii N., Tran T.T., Rogers M.J., Jessen N., Li Y., Liew C.W., Ho R.C., Hirshman M.F., Kulkarni R.N., Kahn C.R., Goodyear L.J. Skeletal muscle-selective knockout of LKB1 increases insulin sensitivity, improves glucose homeostasis, and decreases TRB3. Mol Cell Biol 2006, 26:8217-8227.
24. Sakamoto K., McCarthy A., Smith D., Green K.A., Grahame Hardie D., Ashworth A., Alessi D.R. Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction. Embo J 2005, 24:1810-1820.
25. Hawley S.A., Boudeau J., Reid J.L., Mustard K.J., Udd L., Makela T.P., Alessi D.R., Hardie D.G. Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J Biol 2003, 2:28.
26. Woods A., Johnstone S.R., Dickerson K., Leiper F.C., Fryer L.G., Neumann D., Schlattner U., Wallimann T., Carlson M., Carling D. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol 2003, 13:2004-2008.
27. Hirosumi J., Tuncman G., Chang L., Görgün C.Z., Uysal K.T., Maeda K., Karin M., Hatamisligil G.S. A central role for JNK in obesity and insulin resistance. Nature 2002, 420:333-336.
28. Purves T., Middlemas A., Agthong S., Jude E.B., Boulton A.J., Fernyhough P., Tomlinson D.R. A role for mitogen-activated protein kinases in the etiology of diabetic neuropathy. FASEB J 2001, 15:2508-2514.
29. 307. J Biol Chem 2000, 275:9047-9054.
30. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., Wu M., Ventre J., Doebber T., Fujii N., Musi N., Hirshman M.F., Goodyear L.J., Moller D.E. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001, 108:1167-1174.
31. Zang M., Zuccollo A., Hou X., Nagata D., Walsh K., Herscovitz H., Brecher P., Ruderman N.B., Cohen R.A. AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells. J Biol Chem 2004, 279:47898-47905.
32. Nakatani Y., Kaneto H., Kawamori D., Hatazaki M., Miyatsuka T., Matsuoka T.A., Kajimoto Y., Matsuhisa M., Yamasaki Y., Hori M. Modulation of the JNK pathway in liver affects insulin resistance status. J Biol Chem 2004, 279:45803-45809.